Physician

James Carey Pate, M.D.

According to 2025 Medicare claims, James Pate, M.D. (NPI: 1518107671) practices ophthalmology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is RETINA ASSOCIATES, PLLC (NPI: 1760408397; TIN: 562043271) and primary practice location at 27609-7327.

Pate's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,320 traditional Medicare patients, billed 40,331 HCPCS/CPT codes, and received $5,443,711 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 646 prescription claims across 201 beneficiaries totaling $33,205 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 22 records totaling $671. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,425,240 to $5,443,711. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,342	16,593	$2,425,240
2016	1,610	19,174	$3,083,997
2017	1,378	18,815	$3,350,145
2018	1,493	20,626	$3,928,138
2019	1,532	22,750	$6,039,903
2020	1,505	21,609	$6,852,818
2021	1,496	20,622	$6,480,220
2022	1,235	19,218	$5,861,125
2023	1,194	28,564	$5,299,795
2024	1,320	40,331	$5,443,711

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	110	335	$29,544
2016	157	502	$56,224
2017	163	609	$59,056
2018	176	707	$70,046
2019	192	773	$80,584
2020	188	708	$77,373
2021	224	695	$72,565
2022	214	657	$64,191
2023	223	676	$52,419
2024	201	646	$33,205

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	496	5,522	$654
67028	Injection of drug into eye	719	2,918	$101
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	295	311	$68
92012	Established patient problem focused exam of visual system	509	617	$63
92134	Imaging of retina	1,282	3,738	$29

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Bromfenac Sodium	Bromfenac Sodium	37	1,151	$5,245
Lumigan	Bimatoprost	13	625	$5,039
Prednisolone Acetate	Prednisolone Acetate	100	4,488	$4,246
Ketorolac Tromethamine	Ketorolac Tromethamine	67	3,505	$1,747
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	76	4,940	$1,114

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$671	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Carey Pate, M.D.?

Tedicare shows public-source Medicare data for James Carey Pate, M.D. (NPI 1518107671), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Carey Pate, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Carey Pate, M.D.?

James Carey Pate, M.D. is linked to RETINA ASSOCIATES, PLLC (billing NPI 1760408397) in the available physician profile data.

Does James Carey Pate, M.D. have Open Payments data?

James Carey Pate, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.